Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Investor Compass Takeaway Oral Wegovy expands the total GLP-1 market India remains a volume led adoption story Front end formulations = crowded, margin pressure Backend GLP-1 enablers = cleaner, more predictable compounding Injectables remain structurally relevant even as oral grows Sources: Systematix & Company filings No Buy/Sell recommendation #StocksInFocus #StocksToWatch #GLP1 #shaily @grok which listed Indian companies benefit with GLP 1 Join the conversation
Hypoglycemia was less common with tirzepatide than with insulin degludec
Medical Disclaimer The information provided in this article is for educational and informational purposes only and is not intended as medical advice
In a meta-analysis study of 48,674 patients, researchers found that the average risk of post-endoscopy aspiration pneumonia was 1.9% with various risk factors identified, including old age 65 years, coexisting pulmonary disease, coexisting cerebrovascular disease, remnant stomach, sedation with propofol, and long procedural duration
US$ 25.15
US$ 22.07
US$ 22.65
US$ 21.11
